P&G is looking for partners and solutions that support the deactivation, reduction, or elimination of airborne enzyme particles within production environments across operations.
Broad-acting Peptide Conjugate Antiviral Platform
Barbara Hibner; Co-Founder and CSO, Decoy Therapeutics